Screener
Bruker BRKR Bsi Biospin — Restructuring And Related Cost Incurred Cost
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bruker in its filing.
Tagged under the XBRL concept us-gaap:RestructuringAndRelatedCostIncurredCost.
The source filing: Bruker’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:24 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335226
| Line item | Three Months Ended June 30, 2026 | Six Months Ended June 30, 2026 |
|---|---|---|
| BSI BioSpin | ||
| Severance and termination charges (a) | $0.7 | $2.0 |
| Inventory product restructuring charges | 0.5 | 0.5 |
| Total BSI BioSpin | $1.2 | $2.5 |
| BSI CALID | ||
| Severance and termination charges | $0.9 | $0.9 |
| Other restructuring charges | 0.1 | 0.1 |
| Total BSI CALID | $1.0 | $1.0 |
ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Bruker's bsi biospin — restructuring and related cost incurred cost?
- Bruker (BRKR) reported bsi biospin — restructuring and related cost incurred cost of $1.2M in Q2 2026.
- How has Bruker's bsi biospin — restructuring and related cost incurred cost changed year-over-year?
- Bruker's bsi biospin — restructuring and related cost incurred cost increased by 100.0% year-over-year, from $600K to $1.2M.
- What does bsi biospin — restructuring and related cost incurred cost mean?
- This represents the actual cash or accrual costs incurred by the BioSpin segment specifically tied to the execution of restructuring initiatives. It provides transparency into the financial impact of strategic shifts beyond the initial charge. Tracking this helps investors understand the total cost of organizational transformation.
Ask your AI about Bruker's bsi biospin — restructuring and related cost incurred cost.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude